nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—muscle cancer	0.521	0.836	CbGaD
Acetylsalicylic acid—PTGS2—muscle cancer	0.102	0.164	CbGaD
Acetylsalicylic acid—SLC22A7—Methotrexate—muscle cancer	0.0353	0.188	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—muscle cancer	0.0307	0.164	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—muscle cancer	0.0259	0.138	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—muscle cancer	0.0179	0.0957	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—muscle cancer	0.015	0.0801	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—muscle cancer	0.015	0.0798	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—muscle cancer	0.0128	0.0682	CbGbCtD
Acetylsalicylic acid—ABCB1—Vincristine—muscle cancer	0.0111	0.059	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—muscle cancer	0.0101	0.054	CbGbCtD
Acetylsalicylic acid—TP53—larynx—muscle cancer	0.00776	0.103	CbGeAlD
Acetylsalicylic acid—ABCB1—Doxorubicin—muscle cancer	0.00691	0.0368	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—muscle cancer	0.00669	0.0357	CbGbCtD
Acetylsalicylic acid—TP53—arm—muscle cancer	0.00575	0.0765	CbGeAlD
Acetylsalicylic acid—TP53—appendage—muscle cancer	0.00517	0.0687	CbGeAlD
Acetylsalicylic acid—TP53—manus—muscle cancer	0.00512	0.0681	CbGeAlD
Acetylsalicylic acid—TP53—embryo—muscle cancer	0.00172	0.0228	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—muscle cancer	0.00169	0.0225	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—muscle cancer	0.00165	0.022	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—muscle cancer	0.00141	0.0187	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—muscle cancer	0.00135	0.0179	CbGeAlD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—muscle cancer	0.00133	0.0177	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—muscle cancer	0.0013	0.0173	CbGeAlD
Acetylsalicylic acid—TP53—renal system—muscle cancer	0.0013	0.0173	CbGeAlD
Acetylsalicylic acid—NFKBIA—renal system—muscle cancer	0.00128	0.017	CbGeAlD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—muscle cancer	0.00127	0.35	CbGdCrCtD
Acetylsalicylic acid—HSPA5—renal system—muscle cancer	0.00125	0.0166	CbGeAlD
Acetylsalicylic acid—PTGS2—hindlimb—muscle cancer	0.00116	0.0154	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiac atrium—muscle cancer	0.00114	0.0152	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiac atrium—muscle cancer	0.00112	0.0149	CbGeAlD
Acetylsalicylic acid—RPS6KA3—renal system—muscle cancer	0.00107	0.0142	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—muscle cancer	0.00104	0.0138	CbGeAlD
Acetylsalicylic acid—TP53—tendon—muscle cancer	0.00101	0.0135	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—muscle cancer	0.000997	0.0133	CbGeAlD
Acetylsalicylic acid—PTGS2—appendage—muscle cancer	0.000995	0.0132	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—muscle cancer	0.000982	0.0131	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—muscle cancer	0.000977	0.013	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—muscle cancer	0.000966	0.0128	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—muscle cancer	0.00096	0.265	CbGdCrCtD
Acetylsalicylic acid—RPS6KA3—cardiac atrium—muscle cancer	0.000954	0.0127	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—muscle cancer	0.000946	0.0126	CbGeAlD
Acetylsalicylic acid—TP53—vagina—muscle cancer	0.00094	0.0125	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—muscle cancer	0.000925	0.0123	CbGeAlD
Acetylsalicylic acid—HSPA5—vagina—muscle cancer	0.000906	0.0121	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—muscle cancer	0.0009	0.338	CrCbGaD
Acetylsalicylic acid—Metabolic acidosis—Etoposide—muscle cancer	0.000876	0.0382	CcSEcCtD
Acetylsalicylic acid—TP53—head—muscle cancer	0.000869	0.0116	CbGeAlD
Acetylsalicylic acid—NFKBIA—head—muscle cancer	0.000855	0.0114	CbGeAlD
Acetylsalicylic acid—TP53—testis—muscle cancer	0.000839	0.0112	CbGeAlD
Acetylsalicylic acid—HSPA5—head—muscle cancer	0.000837	0.0111	CbGeAlD
Acetylsalicylic acid—RPS6KA3—tendon—muscle cancer	0.000832	0.0111	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—muscle cancer	0.000826	0.011	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—muscle cancer	0.000817	0.0109	CbGeAlD
Acetylsalicylic acid—HSPA5—testis—muscle cancer	0.000809	0.0108	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—muscle cancer	0.000806	0.0107	CbGeAlD
Acetylsalicylic acid—Eruption—Dactinomycin—muscle cancer	0.000778	0.0339	CcSEcCtD
Acetylsalicylic acid—EDNRA—cardiac atrium—muscle cancer	0.000776	0.0103	CbGeAlD
Acetylsalicylic acid—RPS6KA3—vagina—muscle cancer	0.000772	0.0103	CbGeAlD
Acetylsalicylic acid—SLC22A7—renal system—muscle cancer	0.000763	0.0102	CbGeAlD
Acetylsalicylic acid—RPS6KA3—head—muscle cancer	0.000713	0.00948	CbGeAlD
Acetylsalicylic acid—RPS6KA3—testis—muscle cancer	0.000689	0.00916	CbGeAlD
Acetylsalicylic acid—EDNRA—tendon—muscle cancer	0.000676	0.009	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—muscle cancer	0.000627	0.00835	CbGeAlD
Acetylsalicylic acid—Diabetic—Methotrexate—muscle cancer	0.000621	0.0271	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Dactinomycin—muscle cancer	0.00062	0.027	CcSEcCtD
Acetylsalicylic acid—Coagulopathy—Dactinomycin—muscle cancer	0.000615	0.0268	CcSEcCtD
Acetylsalicylic acid—IKBKB—tendon—muscle cancer	0.000614	0.00817	CbGeAlD
Acetylsalicylic acid—IKBKB—vagina—muscle cancer	0.00057	0.00758	CbGeAlD
Acetylsalicylic acid—EDNRA—testis—muscle cancer	0.00056	0.00745	CbGeAlD
Acetylsalicylic acid—IKBKB—head—muscle cancer	0.000526	0.007	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—muscle cancer	0.000524	0.197	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—muscle cancer	0.000517	0.194	CrCbGaD
Acetylsalicylic acid—IKBKB—testis—muscle cancer	0.000508	0.00676	CbGeAlD
Acetylsalicylic acid—Ulcer—Dactinomycin—muscle cancer	0.000506	0.0221	CcSEcCtD
Acetylsalicylic acid—SLC22A7—testis—muscle cancer	0.000493	0.00656	CbGeAlD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—muscle cancer	0.000463	0.128	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—muscle cancer	0.000463	0.128	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—muscle cancer	0.000463	0.128	CbGdCrCtD
Acetylsalicylic acid—Hepatotoxicity—Etoposide—muscle cancer	0.000449	0.0196	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Vincristine—muscle cancer	0.000435	0.019	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—muscle cancer	0.000402	0.151	CrCbGaD
Acetylsalicylic acid—Chest discomfort—Etoposide—muscle cancer	0.000391	0.0171	CcSEcCtD
Acetylsalicylic acid—Coma—Vincristine—muscle cancer	0.000391	0.017	CcSEcCtD
Acetylsalicylic acid—Kidney function abnormal—Doxorubicin—muscle cancer	0.000372	0.0162	CcSEcCtD
Acetylsalicylic acid—Ulcer—Etoposide—muscle cancer	0.000366	0.016	CcSEcCtD
Acetylsalicylic acid—Polyuria—Vincristine—muscle cancer	0.000353	0.0154	CcSEcCtD
Acetylsalicylic acid—Deafness—Vincristine—muscle cancer	0.000347	0.0151	CcSEcCtD
Acetylsalicylic acid—Eruption—Methotrexate—muscle cancer	0.000337	0.0147	CcSEcCtD
Acetylsalicylic acid—PTGS2—embryo—muscle cancer	0.00033	0.0044	CbGeAlD
Acetylsalicylic acid—CYP2C8—renal system—muscle cancer	0.000323	0.00429	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—muscle cancer	0.000322	0.121	CrCbGaD
Acetylsalicylic acid—Liver disorder—Methotrexate—muscle cancer	0.000304	0.0133	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Methotrexate—muscle cancer	0.000299	0.013	CcSEcCtD
Acetylsalicylic acid—ALB—testis—muscle cancer	0.000297	0.00395	CbGeAlD
Acetylsalicylic acid—Eruption—Doxorubicin—muscle cancer	0.000292	0.0127	CcSEcCtD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—muscle cancer	0.000272	0.00362	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Methotrexate—muscle cancer	0.000269	0.0117	CcSEcCtD
Acetylsalicylic acid—CYP2C19—vagina—muscle cancer	0.000268	0.00356	CbGeAlD
Acetylsalicylic acid—PTGS1—renal system—muscle cancer	0.000262	0.00348	CbGeAlD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—muscle cancer	0.00026	0.00346	CbGeAlD
Acetylsalicylic acid—Haematemesis—Doxorubicin—muscle cancer	0.000259	0.0113	CcSEcCtD
Acetylsalicylic acid—PTGS2—renal system—muscle cancer	0.00025	0.00333	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiac atrium—muscle cancer	0.000234	0.00312	CbGeAlD
Acetylsalicylic acid—CYP2C8—vagina—muscle cancer	0.000234	0.00311	CbGeAlD
Acetylsalicylic acid—Sweating—Vincristine—muscle cancer	0.000229	0.01	CcSEcCtD
Acetylsalicylic acid—Flushing—Dactinomycin—muscle cancer	0.000223	0.00972	CcSEcCtD
Acetylsalicylic acid—Ulcer—Methotrexate—muscle cancer	0.000219	0.00956	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Methotrexate—muscle cancer	0.000211	0.00921	CcSEcCtD
Acetylsalicylic acid—CYP2C8—testis—muscle cancer	0.000209	0.00277	CbGeAlD
Acetylsalicylic acid—ABCB1—embryo—muscle cancer	0.000204	0.00272	CbGeAlD
Acetylsalicylic acid—PTGS1—tendon—muscle cancer	0.000204	0.00272	CbGeAlD
Acetylsalicylic acid—Melaena—Methotrexate—muscle cancer	0.000203	0.00883	CcSEcCtD
Acetylsalicylic acid—PTGS2—tendon—muscle cancer	0.000195	0.0026	CbGeAlD
Acetylsalicylic acid—Anaemia—Dactinomycin—muscle cancer	0.000193	0.00843	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—muscle cancer	0.00019	0.00828	CcSEcCtD
Acetylsalicylic acid—Coma—Methotrexate—muscle cancer	0.00019	0.00826	CcSEcCtD
Acetylsalicylic acid—PTGS1—vagina—muscle cancer	0.00019	0.00252	CbGeAlD
Acetylsalicylic acid—PTGS2—bone marrow—muscle cancer	0.000189	0.00252	CbGeAlD
Acetylsalicylic acid—Leukopenia—Dactinomycin—muscle cancer	0.000187	0.00816	CcSEcCtD
Acetylsalicylic acid—PTGS2—vagina—muscle cancer	0.000181	0.00241	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—muscle cancer	0.00018	0.00783	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—muscle cancer	0.000175	0.00765	CcSEcCtD
Acetylsalicylic acid—PTGS1—head—muscle cancer	0.000175	0.00233	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—muscle cancer	0.000173	0.00755	CcSEcCtD
Acetylsalicylic acid—Anaemia—Vincristine—muscle cancer	0.000173	0.00753	CcSEcCtD
Acetylsalicylic acid—Agitation—Vincristine—muscle cancer	0.000172	0.00749	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—muscle cancer	0.000171	0.00748	CcSEcCtD
Acetylsalicylic acid—PTGS1—testis—muscle cancer	0.000169	0.00225	CbGeAlD
Acetylsalicylic acid—Vertigo—Vincristine—muscle cancer	0.000168	0.00732	CcSEcCtD
Acetylsalicylic acid—PTGS2—head—muscle cancer	0.000167	0.00223	CbGeAlD
Acetylsalicylic acid—Leukopenia—Vincristine—muscle cancer	0.000167	0.00729	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—muscle cancer	0.000167	0.00729	CcSEcCtD
Acetylsalicylic acid—Coma—Doxorubicin—muscle cancer	0.000164	0.00716	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vincristine—muscle cancer	0.000162	0.00706	CcSEcCtD
Acetylsalicylic acid—Flushing—Etoposide—muscle cancer	0.000161	0.00704	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vincristine—muscle cancer	0.000161	0.00704	CcSEcCtD
Acetylsalicylic acid—ABCB1—renal system—muscle cancer	0.000155	0.00206	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Vincristine—muscle cancer	0.000153	0.00665	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—muscle cancer	0.00015	0.00654	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vincristine—muscle cancer	0.000149	0.00651	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Vincristine—muscle cancer	0.000147	0.00643	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—muscle cancer	0.000146	0.00636	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—muscle cancer	0.000141	0.00613	CcSEcCtD
Acetylsalicylic acid—Anaemia—Etoposide—muscle cancer	0.00014	0.0061	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—muscle cancer	0.000137	0.00597	CcSEcCtD
Acetylsalicylic acid—Vertigo—Etoposide—muscle cancer	0.000136	0.00593	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—muscle cancer	0.000136	0.00591	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—muscle cancer	0.000135	0.0059	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—muscle cancer	0.000134	0.00583	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—muscle cancer	0.000133	0.0058	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—muscle cancer	0.000131	0.00572	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—muscle cancer	0.000131	0.0057	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00013	0.00569	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—muscle cancer	0.00013	0.00567	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—muscle cancer	0.000129	0.00562	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—muscle cancer	0.000126	0.00548	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—muscle cancer	0.000125	0.00543	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—muscle cancer	0.000124	0.00539	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—muscle cancer	0.000121	0.00527	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—muscle cancer	0.000121	0.00526	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—muscle cancer	0.000119	0.00521	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—muscle cancer	0.000119	0.00517	CcSEcCtD
Acetylsalicylic acid—ABCB1—bone marrow—muscle cancer	0.000117	0.00156	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—muscle cancer	0.000117	0.00509	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—muscle cancer	0.000116	0.00506	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—muscle cancer	0.000113	0.00491	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—muscle cancer	0.000113	0.00491	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vincristine—muscle cancer	0.000112	0.0049	CcSEcCtD
Acetylsalicylic acid—ABCB1—vagina—muscle cancer	0.000112	0.00149	CbGeAlD
Acetylsalicylic acid—Sweating—Methotrexate—muscle cancer	0.000111	0.00485	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—muscle cancer	0.00011	0.0048	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—muscle cancer	0.00011	0.00479	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—muscle cancer	0.000109	0.00473	CcSEcCtD
Acetylsalicylic acid—Rash—Dactinomycin—muscle cancer	0.000108	0.00469	CcSEcCtD
Acetylsalicylic acid—NFKBIA—B Cell Activation—MDM2—muscle cancer	0.000106	0.00124	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Methotrexate—muscle cancer	0.000105	0.00457	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vincristine—muscle cancer	0.000104	0.00455	CcSEcCtD
Acetylsalicylic acid—TP53—Cell Cycle—BUB1B—muscle cancer	0.000104	0.00122	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000104	0.00121	CbGpPWpGaD
Acetylsalicylic acid—Haemorrhage—Methotrexate—muscle cancer	0.000104	0.00454	CcSEcCtD
Acetylsalicylic acid—ABCB1—head—muscle cancer	0.000104	0.00138	CbGeAlD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000103	0.0012	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—FOXO4—muscle cancer	0.000102	0.00119	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Etoposide—muscle cancer	0.000102	0.00444	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—CDKN2A—muscle cancer	0.000102	0.00119	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Dactinomycin—muscle cancer	0.000101	0.00442	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vincristine—muscle cancer	0.000101	0.0044	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—FOXO4—muscle cancer	0.000101	0.00117	CbGpPWpGaD
Acetylsalicylic acid—Drowsiness—Doxorubicin—muscle cancer	0.0001	0.00438	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KIDINS220—muscle cancer	0.0001	0.00117	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KIDINS220—muscle cancer	0.0001	0.00117	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—testis—muscle cancer	0.0001	0.00133	CbGeAlD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—KIT—muscle cancer	9.94e-05	0.00116	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—MDM2—muscle cancer	9.87e-05	0.00115	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Etoposide—muscle cancer	9.82e-05	0.00428	CcSEcCtD
Acetylsalicylic acid—TP53—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	9.79e-05	0.00114	CbGpPWpGaD
Acetylsalicylic acid—Tinnitus—Methotrexate—muscle cancer	9.71e-05	0.00423	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vincristine—muscle cancer	9.7e-05	0.00423	CcSEcCtD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	9.69e-05	0.00113	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—FOXO4—muscle cancer	9.67e-05	0.00113	CbGpPWpGaD
Acetylsalicylic acid—Sweating—Doxorubicin—muscle cancer	9.63e-05	0.0042	CcSEcCtD
Acetylsalicylic acid—Rash—Vincristine—muscle cancer	9.62e-05	0.00419	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vincristine—muscle cancer	9.61e-05	0.00419	CcSEcCtD
Acetylsalicylic acid—IKBKB—Apoptosis—CDKN2A—muscle cancer	9.56e-05	0.00111	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—KIT—muscle cancer	9.47e-05	0.0011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Transmission across Chemical Synapses—MDM2—muscle cancer	9.31e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—MDM2—muscle cancer	9.27e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—FOXO1—muscle cancer	9.23e-05	0.00107	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet degranulation—IGF2—muscle cancer	9.22e-05	0.00107	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Etoposide—muscle cancer	9.1e-05	0.00397	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	9.09e-05	0.00106	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—muscle cancer	9.07e-05	0.00395	CcSEcCtD
Acetylsalicylic acid—Nausea—Vincristine—muscle cancer	9.06e-05	0.00395	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—muscle cancer	9.02e-05	0.00393	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—FOXO4—muscle cancer	9e-05	0.00105	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	8.96e-05	0.00104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	8.92e-05	0.00104	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—KIT—muscle cancer	8.88e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—IGF2—muscle cancer	8.87e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	8.79e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Etoposide—muscle cancer	8.74e-05	0.00381	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—CD34—muscle cancer	8.63e-05	0.00101	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	8.51e-05	0.000992	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—CDKN2A—muscle cancer	8.5e-05	0.000991	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Etoposide—muscle cancer	8.45e-05	0.00369	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—muscle cancer	8.41e-05	0.00367	CcSEcCtD
Acetylsalicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	8.39e-05	0.000977	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Methotrexate—muscle cancer	8.38e-05	0.00365	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—muscle cancer	8.37e-05	0.00365	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—ENO2—muscle cancer	8.3e-05	0.000967	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—MDM2—muscle cancer	8.25e-05	0.000961	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	8.21e-05	0.000956	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Etoposide—muscle cancer	8.17e-05	0.00356	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—muscle cancer	8.15e-05	0.00355	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—muscle cancer	8.12e-05	0.00354	CcSEcCtD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	8.11e-05	0.000945	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—FOXO1—muscle cancer	7.88e-05	0.000918	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Methotrexate—muscle cancer	7.86e-05	0.00343	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—muscle cancer	7.86e-05	0.00343	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling by NGF—FOXO4—muscle cancer	7.85e-05	0.000915	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—MDM2—muscle cancer	7.83e-05	0.000912	CbGpPWpGaD
Acetylsalicylic acid—Rash—Etoposide—muscle cancer	7.79e-05	0.0034	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—muscle cancer	7.78e-05	0.00339	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—muscle cancer	7.72e-05	0.00337	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—muscle cancer	7.72e-05	0.00337	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—CD34—muscle cancer	7.71e-05	0.000899	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	7.69e-05	0.000896	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—CDKN2A—muscle cancer	7.69e-05	0.000896	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—MED12—muscle cancer	7.62e-05	0.000888	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—FOXO1—muscle cancer	7.54e-05	0.000879	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HMGA1—muscle cancer	7.54e-05	0.000879	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—FOXO1—muscle cancer	7.53e-05	0.000877	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methotrexate—muscle cancer	7.46e-05	0.00325	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—MDM2—muscle cancer	7.46e-05	0.000869	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—MDM2—muscle cancer	7.46e-05	0.000869	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	7.44e-05	0.000867	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—FOXO1—muscle cancer	7.44e-05	0.000867	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—muscle cancer	7.4e-05	0.00323	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—muscle cancer	7.34e-05	0.0032	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—muscle cancer	7.26e-05	0.00316	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—muscle cancer	7.25e-05	0.00316	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—muscle cancer	7.22e-05	0.00315	CcSEcCtD
Acetylsalicylic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	7.19e-05	0.000838	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—muscle cancer	7.15e-05	0.00312	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—FOXO1—muscle cancer	7.14e-05	0.000832	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Neuronal System—MDM2—muscle cancer	7.14e-05	0.000831	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	7.09e-05	0.000826	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.08e-05	0.000825	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Doxorubicin—muscle cancer	7.06e-05	0.00308	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—muscle cancer	7.04e-05	0.00307	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—muscle cancer	7.03e-05	0.00306	CcSEcCtD
Acetylsalicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	7e-05	0.000816	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—MDM2—muscle cancer	7e-05	0.000815	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—ENO2—muscle cancer	6.95e-05	0.00081	CbGpPWpGaD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—muscle cancer	6.9e-05	0.00301	CcSEcCtD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	6.87e-05	0.0008	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Doxorubicin—muscle cancer	6.8e-05	0.00297	CcSEcCtD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	6.79e-05	0.000791	CbGpPWpGaD
Acetylsalicylic acid—Hypertension—Doxorubicin—muscle cancer	6.78e-05	0.00296	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—FOXO4—muscle cancer	6.76e-05	0.000788	CbGpPWpGaD
Acetylsalicylic acid—Chest pain—Doxorubicin—muscle cancer	6.69e-05	0.00291	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—muscle cancer	6.69e-05	0.00291	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PTCH1—muscle cancer	6.67e-05	0.000778	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PTCH1—muscle cancer	6.67e-05	0.000778	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—FOXO1—muscle cancer	6.65e-05	0.000775	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Methotrexate—muscle cancer	6.6e-05	0.00288	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—muscle cancer	6.58e-05	0.00287	CcSEcCtD
Acetylsalicylic acid—HSPA5—Hemostasis—VEGFA—muscle cancer	6.55e-05	0.000764	CbGpPWpGaD
Acetylsalicylic acid—Dyspepsia—Methotrexate—muscle cancer	6.51e-05	0.00284	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	6.48e-05	0.000755	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Doxorubicin—muscle cancer	6.46e-05	0.00282	CcSEcCtD
Acetylsalicylic acid—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	6.42e-05	0.000748	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—muscle cancer	6.41e-05	0.00279	CcSEcCtD
Acetylsalicylic acid—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	6.37e-05	0.000743	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD34—muscle cancer	6.32e-05	0.000737	CbGpPWpGaD
Acetylsalicylic acid—Shock—Doxorubicin—muscle cancer	6.31e-05	0.00275	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—muscle cancer	6.27e-05	0.00274	CcSEcCtD
Acetylsalicylic acid—TP53—Cellular responses to stress—VEGFA—muscle cancer	6.26e-05	0.00073	CbGpPWpGaD
Acetylsalicylic acid—Tachycardia—Doxorubicin—muscle cancer	6.25e-05	0.00273	CcSEcCtD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	6.24e-05	0.000727	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—p75(NTR)-mediated signaling—TP53—muscle cancer	6.23e-05	0.000725	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CNR1—muscle cancer	6.2e-05	0.000723	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	6.2e-05	0.000723	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—muscle cancer	6.2e-05	0.0027	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TP53—muscle cancer	6.14e-05	0.000716	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—muscle cancer	6.1e-05	0.00266	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—KIT—muscle cancer	6e-05	0.000699	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Methotrexate—muscle cancer	5.88e-05	0.00256	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—FOXO4—muscle cancer	5.87e-05	0.000683	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	5.86e-05	0.000682	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—FOXO1—muscle cancer	5.8e-05	0.000675	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—KIT—muscle cancer	5.75e-05	0.00067	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—muscle cancer	5.71e-05	0.00249	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—muscle cancer	5.7e-05	0.00248	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KIT—muscle cancer	5.67e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—VEGFA—muscle cancer	5.66e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—TP53—muscle cancer	5.66e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—muscle cancer	5.64e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CNR1—muscle cancer	5.63e-05	0.000656	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CNR1—muscle cancer	5.63e-05	0.000656	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PTCH1—muscle cancer	5.51e-05	0.000642	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—muscle cancer	5.45e-05	0.00238	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KIT—muscle cancer	5.44e-05	0.000634	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.43e-05	0.000633	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	5.35e-05	0.000623	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TP53—muscle cancer	5.32e-05	0.00062	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—muscle cancer	5.28e-05	0.0023	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—FOXO4—muscle cancer	5.24e-05	0.000611	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Methotrexate—muscle cancer	5.24e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	5.11e-05	0.000595	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Doxorubicin—muscle cancer	5.09e-05	0.00222	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KIT—muscle cancer	5.07e-05	0.00059	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Methotrexate—muscle cancer	5.06e-05	0.00221	CcSEcCtD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	5.02e-05	0.000585	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.01e-05	0.000584	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—FOXO1—muscle cancer	5e-05	0.000582	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TP53—muscle cancer	4.99e-05	0.000581	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIDINS220—muscle cancer	4.98e-05	0.00058	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—TP53—muscle cancer	4.95e-05	0.000577	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Methotrexate—muscle cancer	4.89e-05	0.00213	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Axon guidance—VEGFA—muscle cancer	4.81e-05	0.00056	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—CDKN2A—muscle cancer	4.77e-05	0.000556	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—FOXO4—muscle cancer	4.74e-05	0.000552	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—MDM2—muscle cancer	4.73e-05	0.000551	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—muscle cancer	4.72e-05	0.00206	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—muscle cancer	4.71e-05	0.00205	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—muscle cancer	4.67e-05	0.00203	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—muscle cancer	4.66e-05	0.00203	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CNR1—muscle cancer	4.65e-05	0.000542	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—MDM2—muscle cancer	4.62e-05	0.000539	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	4.55e-05	0.00053	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Doxorubicin—muscle cancer	4.53e-05	0.00198	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—MDM2—muscle cancer	4.53e-05	0.000527	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—FOXO4—muscle cancer	4.48e-05	0.000522	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—MDM2—muscle cancer	4.46e-05	0.00052	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KIT—muscle cancer	4.42e-05	0.000515	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTCH1—muscle cancer	4.41e-05	0.000514	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Methotrexate—muscle cancer	4.4e-05	0.00192	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—muscle cancer	4.38e-05	0.00191	CcSEcCtD
Acetylsalicylic acid—TP53—Signaling Pathways—PTCH1—muscle cancer	4.36e-05	0.000508	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—ANGPT2—muscle cancer	4.34e-05	0.000505	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—FOXO1—muscle cancer	4.33e-05	0.000505	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—FOXO4—muscle cancer	4.3e-05	0.000501	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—MDM2—muscle cancer	4.29e-05	0.000499	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—TP53—muscle cancer	4.28e-05	0.000499	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Doxorubicin—muscle cancer	4.24e-05	0.00185	CcSEcCtD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	4.09e-05	0.000477	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Doxorubicin—muscle cancer	4.07e-05	0.00178	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—muscle cancer	4.04e-05	0.00176	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—muscle cancer	4.04e-05	0.00176	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—MDM2—muscle cancer	3.99e-05	0.000465	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.98e-05	0.000464	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.95e-05	0.000461	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—FH—muscle cancer	3.95e-05	0.00046	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTCH1—muscle cancer	3.94e-05	0.000459	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTCH1—muscle cancer	3.94e-05	0.000459	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—FOXO1—muscle cancer	3.87e-05	0.000451	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet degranulation—VEGFA—muscle cancer	3.87e-05	0.000451	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD34—muscle cancer	3.84e-05	0.000447	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Doxorubicin—muscle cancer	3.81e-05	0.00166	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—KIT—muscle cancer	3.81e-05	0.000443	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IGF2—muscle cancer	3.8e-05	0.000443	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—FOXO4—muscle cancer	3.79e-05	0.000442	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—FOXO4—muscle cancer	3.75e-05	0.000437	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CNR1—muscle cancer	3.72e-05	0.000434	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—VEGFA—muscle cancer	3.72e-05	0.000434	CbGpPWpGaD
Acetylsalicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	3.69e-05	0.000429	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CNR1—muscle cancer	3.68e-05	0.000429	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—FOXO1—muscle cancer	3.5e-05	0.000408	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—MDM2—muscle cancer	3.48e-05	0.000405	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—VEGFA—muscle cancer	3.43e-05	0.0004	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—VEGFA—muscle cancer	3.42e-05	0.000399	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—muscle cancer	3.41e-05	0.000397	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FOXO4—muscle cancer	3.39e-05	0.000395	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FOXO4—muscle cancer	3.39e-05	0.000395	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CNR1—muscle cancer	3.33e-05	0.000388	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CNR1—muscle cancer	3.33e-05	0.000388	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—FOXO1—muscle cancer	3.31e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KIT—muscle cancer	3.3e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.24e-05	0.000377	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.22e-05	0.000375	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—FOXO1—muscle cancer	3.18e-05	0.00037	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.14e-05	0.000366	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—FH—muscle cancer	3.14e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—muscle cancer	3.06e-05	0.000356	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF2—muscle cancer	3.04e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF2—muscle cancer	3.01e-05	0.00035	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MDM2—muscle cancer	3e-05	0.000349	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KIT—muscle cancer	2.95e-05	0.000344	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.89e-05	0.000337	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—muscle cancer	2.89e-05	0.000337	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—FOXO1—muscle cancer	2.8e-05	0.000326	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—FOXO1—muscle cancer	2.77e-05	0.000323	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF2—muscle cancer	2.72e-05	0.000317	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF2—muscle cancer	2.72e-05	0.000317	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KIT—muscle cancer	2.67e-05	0.000311	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—muscle cancer	2.65e-05	0.000308	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.64e-05	0.000307	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOXO4—muscle cancer	2.61e-05	0.000304	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MDM2—muscle cancer	2.6e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—FH—muscle cancer	2.55e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—FH—muscle cancer	2.54e-05	0.000296	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KIT—muscle cancer	2.52e-05	0.000294	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FOXO1—muscle cancer	2.5e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FOXO1—muscle cancer	2.5e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—muscle cancer	2.42e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KIT—muscle cancer	2.42e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.38e-05	0.000278	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MDM2—muscle cancer	2.32e-05	0.000271	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—FH—muscle cancer	2.28e-05	0.000265	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MED12—muscle cancer	2.23e-05	0.00026	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.23e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—FH—muscle cancer	2.22e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.15e-05	0.00025	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KIT—muscle cancer	2.13e-05	0.000249	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KIT—muscle cancer	2.11e-05	0.000246	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF2—muscle cancer	2.11e-05	0.000246	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MDM2—muscle cancer	2.1e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FH—muscle cancer	2.08e-05	0.000242	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO2—muscle cancer	2.04e-05	0.000237	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MDM2—muscle cancer	1.98e-05	0.000231	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTCH1—muscle cancer	1.96e-05	0.000228	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO2—muscle cancer	1.93e-05	0.000225	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOXO1—muscle cancer	1.93e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KIT—muscle cancer	1.91e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KIT—muscle cancer	1.91e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—MDM2—muscle cancer	1.91e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.8e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MED12—muscle cancer	1.77e-05	0.000206	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HMGA1—muscle cancer	1.75e-05	0.000204	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	1.72e-05	0.0002	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.69e-05	0.000197	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FOXO4—muscle cancer	1.69e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MDM2—muscle cancer	1.68e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MDM2—muscle cancer	1.66e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CNR1—muscle cancer	1.65e-05	0.000193	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO2—muscle cancer	1.62e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—muscle cancer	1.59e-05	0.000186	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.59e-05	0.000185	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FOXO4—muscle cancer	1.57e-05	0.000183	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MDM2—muscle cancer	1.5e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MDM2—muscle cancer	1.5e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KIT—muscle cancer	1.47e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MED12—muscle cancer	1.44e-05	0.000168	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MED12—muscle cancer	1.43e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF2—muscle cancer	1.35e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO2—muscle cancer	1.31e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO2—muscle cancer	1.31e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MED12—muscle cancer	1.29e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.28e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—muscle cancer	1.28e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—muscle cancer	1.26e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MED12—muscle cancer	1.26e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FOXO1—muscle cancer	1.25e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—muscle cancer	1.2e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MED12—muscle cancer	1.17e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO2—muscle cancer	1.17e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FOXO1—muscle cancer	1.16e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MDM2—muscle cancer	1.16e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO2—muscle cancer	1.15e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—muscle cancer	1.14e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—muscle cancer	1.14e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO2—muscle cancer	1.07e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.03e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.02e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—muscle cancer	9.64e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—muscle cancer	9.49e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.18e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—muscle cancer	8.85e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—muscle cancer	8.85e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—muscle cancer	8.62e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—muscle cancer	8.62e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.37e-06	9.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—muscle cancer	7.47e-06	8.71e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—muscle cancer	7.09e-06	8.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—muscle cancer	6.97e-06	8.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—muscle cancer	6.68e-06	7.79e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—muscle cancer	5.67e-06	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—muscle cancer	4.58e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—muscle cancer	4.55e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—muscle cancer	4.29e-06	5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—muscle cancer	4.09e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—muscle cancer	3.99e-06	4.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—muscle cancer	3.73e-06	4.34e-05	CbGpPWpGaD
